Expert Opinion on Biological Therapy

3.2k papers and 76.7k indexed citations i.

About

The 3.2k papers published in Expert Opinion on Biological Therapy in the last decades have received a total of 76.7k indexed citations. Papers published in Expert Opinion on Biological Therapy usually cover Molecular Biology (1.1k papers), Immunology (889 papers) and Oncology (782 papers) specifically the topics of Immunotherapy and Immune Responses (353 papers), Virus-based gene therapy research (350 papers) and CAR-T cell therapy research (318 papers). The most active scholars publishing in Expert Opinion on Biological Therapy are Luca Bianchi, Marco Galluzzo, Nicola Maffulli, Mark S. Talamonti and Silvio Danese.

In The Last Decade

Fields of papers published in Expert Opinion on Biological Therapy

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Expert Opinion on Biological Therapy. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Expert Opinion on Biological Therapy

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Expert Opinion on Biological Therapy. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Expert Opinion on Biological Therapy with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025